Vol 39, No 9 (September 2018): Acta Pharmacologica Sinica

Review Article

MicroRNAs as biomarkers for human glioblastoma: progress and potential Pages:1405–1413
Shi-wei HUANG, Ni-da ALI, Lily ZHONG, Jian SHI
Functions and the related signaling pathways of the neurotrophic factor neuritin Pages:1414–1420
Jin-jing YAO, Qian-ru ZHAO, Jun-mei LU, Yan-ai MEI

Article

Suppression of MIF-induced neuronal apoptosis may underlie the therapeutic effects of effective components of Fufang Danshen in the treatment of Alzheimer’s disease Pages:1421–1438
Cheng-jie LIANG, Jia-huang LI, Zhen ZHANG, Ju-yan ZHANG, Shu-qun LIU, Jie YANG
Cyanidin attenuates Aβ25-35-induced neuroinflammation by suppressing NF-κB activity downstream of TLR4/NOX4 in human neuroblastoma cells Pages:1439–1452
Sarinthorn THUMMAYOT, Chainarong TOCHARUS, Pichaya JUMNONGPRAKHON, Apichart SUKSAMRARN, Jiraporn TOCHARUS
Correlation of the predisposition of Chinese children to cerebral palsy with nucleotide variation in primiR- 124 that alters the non-canonical apoptosis pathway Pages:1453–1462
Hui LI, Xiu-li WANG, Yan-qiu WU, Xiu-mei LIU, Ai-min LI
Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression Pages:1463–1472
Shu-juan PAN, Yun-long TAN, Shang-wu YAO, Yu XIN, Xuan YANG, Jing LIU, Jing XIONG
Proteomics analysis reveals a potential new target protein for the lipid-lowering effect of Berberine8998 Pages:1473–1482
Cheng-yin YU, Gang-yi LIU, Xiao-hui LIU, Yu-zhou GUI, Hai-ming LIU, Hong-chao ZHENG, Darek C GORECKI, Asmita V PATEL, Chen YU, Yi-ping WANG
A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo Pages:1483–1492
Tao GUO, Zu-long LIU, Qiang ZHAO, Zhi-min ZHAO, Cheng-hai LIU
Ursodeoxycholic acid protects interstitial Cajal-like cells in the gallbladder from undergoing apoptosis by inhibiting TNF-α expression Pages:1493–1500
Jiang-fan WAN, Shi-feng CHU, Xin ZHOU, Yue-ting LI, Wen-bin HE, Feng TAN, Piao LUO, Qi-di AI, Qi WANG, Nai-hong CHEN
Neotuberostemonine inhibits the differentiation of lung fibroblasts into myofibroblasts in mice by regulating HIF-1α signaling Pages:1501–1512
Xin-miao LV, Ming-dan LI, Si CHENG, Bao-lin LIU, Kang LIU, Chao-feng ZHANG, Xiang-hong XU, Mian ZHANG
SND p102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad3 pathway Pages:1513–1521
Jin-lan XU, Xin-xin GAN, Jun NI, De-cui SHAO, Yang SHEN, Nai-jun MIAO, Dan XU, Li ZHOU, Wei ZHANG, Li-min LU
Novel in vitro dynamic metabolic system for predicting the human pharmacokinetics of tolbutamide Pages:1522–1532
Cai-fu XUE, Zhe ZHANG, Yan JIN, Bin ZHU, Jun-fen XING, Guo MA, Xiao-qiang XIANG, Wei-min CAI
Whole-body physiology-based pharmacokinetics of caspofungin for general patients, intensive care unit patients and hepatic insufficiency patients Pages:1533–1543
Qian-ting YANG, Ya-jing ZHAI, Lu CHEN, Tao ZHANG, Yan YAN, Ti MENG, Lei-chao LIU, Li-mei CHEN, Xue WANG, Ya-lin DONG
Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay Pages:1544–1552
Tian LU, Jun-chi HU, Wen-chao LU, Jie HAN, Hong DING, Hao JIANG, Yuan-yuan ZHANG, Li-yan YUE, Shi-jie CHEN, Hua-liang JIANG, Kai-xian CHEN, Hui-fang CHAI, Cheng LUO